[Personalized systemic treatment of metastatic colorectal cancer].
Personalisierte Systemtherapie beim metastasierten kolorektalen Karzinom.
Colorectal neoplasms, drug therapy, combination
Molecular targeted therapy
Neoplasm metastasis, liver
Neoplasm metastasis, lung
Palliative care
Journal
Der Internist
ISSN: 1432-1289
Titre abrégé: Internist (Berl)
Pays: Germany
ID NLM: 0264620
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
pubmed:
5
6
2020
medline:
21
7
2020
entrez:
5
6
2020
Statut:
ppublish
Résumé
This article deals with the treatment of metastatic colorectal cancer (stage IV). The treatment goals and approaches are determined by the resectability status of the metastases: resectable liver and lung metastases are primarily resected and perioperative chemotherapy appears to be dispensable. In potentially resectable metastases, a conversion therapy is attempted to enable a potentially curative resection. In the case of nonresectability the treatment goal is palliative. Induction and maintenance therapy as well as drug holidays are suggested in an attempt to achieve extended survival while maintaining the quality of life, beginning with the best possible individual treatment. For some patients with stage IV, molecular targeted therapies are available. The study situation and approval status are dealt with in detail. With improved molecular characterization of tumors the treatment can be further individualized.
Identifiants
pubmed: 32494899
doi: 10.1007/s00108-020-00808-x
pii: 10.1007/s00108-020-00808-x
doi:
Types de publication
Journal Article
Langues
ger
Sous-ensembles de citation
IM